Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A
Launched in Thailand, the ASEAN hub, marking an early entry into the fast-growing combination therapy market (DPP-4 and SGLT-2 inhibitor combination) with strong potential for market leadership
Previously, Sujatha has held leadership positions at prominent organizations, including Publicis Sapient, Infinite Computer Solutions, and Capgemini
Announces Rs. 317 crore investment in new recycling plant
EBITDA for Q1 FY25 is at Rs. 100 crore compared to Rs. 32 crore in the previous year
The drug will be marketed in different strengths of 150 mg and 440 mg and used in the treatment of patients with HER2
Rusan’s API facility in Ankleshwar is GMP approved by other stringent international agencies as well
The acquisition is immediately accretive and creates a compelling, single-stop, multi-continent partner for biopharma companies
Ashland's nutraceuticals business supplies a broad portfolio of active ingredients and formulation aids to nutritional product companies
Approval from Colombia's INVIMA will accelerate growth in Colombia, by registering our product and getting regular supplies
Subscribe To Our Newsletter & Stay Updated
